Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model

(2012) Heidi Tiller et al.   TRANSFUSION

Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia

(2011) G. Bertrand et al.   BLOOD

Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions

(2011) Marije M. Kamphuis et al.   PRENATAL DIAGNOSIS

Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus

(2010) James B. Bussel et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review

(2010) MM Kamphuis et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy

(2010) P. Chen et al.   BLOOD

Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion

(2010) G. Giers et al.   HAEMATOLOGICA

Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective

(2010) C. A. Vinograd et al.   HAEMATOLOGICA

Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts

(2010) G. Giers et al.   VOX SANGUINIS

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

(2008) M. K. Killie et al.   HAEMATOLOGICA